Search research articles
Contact Us
Filters
Showing results (41-50 of 104) with videos related to
Page
of 11
Sort By:
Atherosclerosis
|
August 9, 2011
Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein
Kristina Duwensee, Stefan Schwaiger, Ivan Tancevski, et al.
Plos One
|
August 31, 2018
The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension
Thomas Sonnweber, Manfred Nairz, Igor Theurl, et al.
ERJ Open Research
|
September 25, 2024
Lipomatous hypertrophy of the interatrial septum: a distinct adipose tissue type in COPD?
Pietro G Lacaita, Benedikt Kindl, Fabian Plank, et al.
Metabolism: Clinical and Experimental
|
July 10, 2007
Scavenger receptor class B type I polymorphisms and peripheral arterial disease
Andreas Ritsch, Gudrun Sonderegger, Gudron Sonderegger, et al.
Traffic (Copenhagen, Denmark)
|
October 22, 2013
Microvillus inclusion disease: loss of Myosin vb disrupts intracellular traffic and cell polarity
Cornelia E Thoeni, Georg F Vogel, Ivan Tancevski, et al.
Clinical Nuclear Medicine
|
October 18, 2022
Enhancing Clinical Diagnosis for Patients With Persistent Pulmonary Abnormalities After COVID-19 Infection: The Potential Benefit of 68 Ga-FAPI PET/CT
Anna Sviridenko, Anna Boehm, Gianpaolo di Santo, et al.
Scientific Reports
|
May 6, 2024
Laboratory parameters related to disease severity and physical performance after reconvalescence of acute COVID-19 infection
Mario Gietl, Francesco Burkert, Stefanie Hofer, et al.
Scientific Reports
|
January 12, 2021
Defining a therapeutic range for regeneration of ischemic myocardium via shock waves
Leo Pölzl, Felix Nägele, Jakob Hirsch, et al.
Respiratory Medicine
|
January 23, 2021
High expression of mTOR signaling in granulomatous lesions is not predictive for the clinical course of sarcoidosis
Alex Pizzini, Hannes Bacher, Magdalena Aichner, et al.
Scientific Reports
|
February 8, 2025
Severe COVID-19 disease is associated with genetic factors affecting plasma ACE2 receptor and CRP concentrations
Verena Vogi, David Haschka, Lukas Forer, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 104) with videos related to
Sort By:
Page
of 11
Atherosclerosis
|
August 9, 2011
Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein
Kristina Duwensee, Stefan Schwaiger, Ivan Tancevski, et al.
Plos One
|
August 31, 2018
The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension
Thomas Sonnweber, Manfred Nairz, Igor Theurl, et al.
ERJ Open Research
|
September 25, 2024
Lipomatous hypertrophy of the interatrial septum: a distinct adipose tissue type in COPD?
Pietro G Lacaita, Benedikt Kindl, Fabian Plank, et al.
Metabolism: Clinical and Experimental
|
July 10, 2007
Scavenger receptor class B type I polymorphisms and peripheral arterial disease
Andreas Ritsch, Gudrun Sonderegger, Gudron Sonderegger, et al.
Traffic (Copenhagen, Denmark)
|
October 22, 2013
Microvillus inclusion disease: loss of Myosin vb disrupts intracellular traffic and cell polarity
Cornelia E Thoeni, Georg F Vogel, Ivan Tancevski, et al.
Clinical Nuclear Medicine
|
October 18, 2022
Enhancing Clinical Diagnosis for Patients With Persistent Pulmonary Abnormalities After COVID-19 Infection: The Potential Benefit of 68 Ga-FAPI PET/CT
Anna Sviridenko, Anna Boehm, Gianpaolo di Santo, et al.
Scientific Reports
|
May 6, 2024
Laboratory parameters related to disease severity and physical performance after reconvalescence of acute COVID-19 infection
Mario Gietl, Francesco Burkert, Stefanie Hofer, et al.
Scientific Reports
|
January 12, 2021
Defining a therapeutic range for regeneration of ischemic myocardium via shock waves
Leo Pölzl, Felix Nägele, Jakob Hirsch, et al.
Respiratory Medicine
|
January 23, 2021
High expression of mTOR signaling in granulomatous lesions is not predictive for the clinical course of sarcoidosis
Alex Pizzini, Hannes Bacher, Magdalena Aichner, et al.
Scientific Reports
|
February 8, 2025
Severe COVID-19 disease is associated with genetic factors affecting plasma ACE2 receptor and CRP concentrations
Verena Vogi, David Haschka, Lukas Forer, et al.
Page
of 11